Metastatic Melanoma with Jason Luke, MD and Jeffrey Weber, MD, PhD
EP. 1: Jason Luke, MD: Factors to Consider When Determining Treatments
Watch
EP. 2: Jason Luke, MD: The Association Between Durable Response and Low Disease Burden
EP. 3: Jason Luke, MD: The Role of LDH, Age, and Sites of Disease in Durability of Response
EP. 4: Jason Luke, MD: Predicting Which Patients Will Experience Durable Responses to Targeted Therapy
EP. 5: Jeffrey Weber, MD, PhD: Factors to Consider When Determining Treatments
EP. 6: Jeffrey Weber, MD, PhD: The Role of LDH, Age, and Sites of Disease in Durability of Response
EP. 7: Jeffrey Weber, MD, PhD: Predicting Which Patients Will Experience Durable Responses to Targeted Therapy
EP. 8: Jeffrey Weber, MD, PhD: The Association Between Durable Response and Low Disease Burden
